Skip to main content
HOPA 2024 Main banner
Final Program


Program Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Saturday, April 6, 2024
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: A Pharmacist's Roadmap to Success
  • 7:00 AM – 8:00 AM ET
    CE Symposium: New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes (LR-MDS): Bridging Clinical Innovation and Practice
  • 8:15 AM – 9:15 AM ET
    Up to My Neck (In Head and Neck Cancer Updates)
  • 8:15 AM – 9:15 AM ET
    1 - Clinical Pearl 1: Challenging the Recognition and Treatment Management for HER2-low Breast Cancer
  • 8:15 AM – 9:15 AM ET
    2 - Clinical Pearl 2: Best Practices – Management of Alpelisib-Induced Hyperglycemia
  • 8:15 AM – 9:15 AM ET
    3 - Clinical Pearl 3: Metastatic Castrate Resistant Prostate Cancer in a State of (Homologous Recombination) Repair: Navigating PARPi Therapy Selection
  • 9:25 AM – 10:25 AM ET
    1 - To Treat or Not To Treat? The Role of Immunotherapy in Non Small Cell Lung Cancer (NSCLC) With Oncogenic Drivers
  • 9:25 AM – 10:25 AM ET
    2 - Research Grant, Part 1: Oncology Pharmacist-Driven Symptom Monitoring System Uncovered Health Disparities in Minoritized Patients Receiving Anticancer Therapies
  • 9:25 AM – 10:25 AM ET
    3 - Research Grant, Part 2: Pharmacist Monitoring of Patient-Reported Outcome Measures (PROMs) for Oral Oncolytics
  • 9:25 AM – 10:25 AM ET
    4 - Updates in Chronic Lymphocytic Leukemia: Sequencing Versus Combination Therapy of Small Molecule Inhibitors
  • 10:35 AM – 11:35 AM ET
    Collaborative Practice in Clinical Trials: Reinforcements for the Crisis in Clinical Research
  • 10:35 AM – 11:35 AM ET
    Igniting Breakthroughs in Pharmacogenetics & Genomics: Unveiling the Pathogenic Potential of VUS Through DEI Enhancement
  • 11:45 AM – 12:45 PM ET
    Non-CE Symposium: Harnessing the Power of Human Immunity
  • 11:45 AM – 12:45 PM ET
    Non-CE Symposium: Long-Term Clinical Trial Results for a BTKi in the Treatment of CLL/SLLa